150 related articles for article (PubMed ID: 36290900)
81. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
82. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
83. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
[TBL] [Abstract][Full Text] [Related]
84. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
85. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
[TBL] [Abstract][Full Text] [Related]
86. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
87. Role of
Albano D; Bosio G; Giubbini R; Bertagna F
Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
[TBL] [Abstract][Full Text] [Related]
88. Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT.
Usmani S; Albader FL; Marafi F; Elhaggracy RS
J Pak Med Assoc; 2022 Jun; 72(6):1241-1242. PubMed ID: 35751349
[TBL] [Abstract][Full Text] [Related]
89. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
90. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract][Full Text] [Related]
91. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
92. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
Schoen M; Braun T; Manava P; Ludwigs S; Lell M
Nuklearmedizin; 2018 Apr; 57(2):50-55. PubMed ID: 29590675
[TBL] [Abstract][Full Text] [Related]
93. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
94. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
Ömür Ö; Baran Y; Oral A; Ceylan Y
Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
[TBL] [Abstract][Full Text] [Related]
95. The Role Of 18F-FDG PET/CT In Evaluation Of Primary CNS Lymphoma: The Path Less Travelled.
Usman S; Jain A; Riyami KA; Naumani SP; Sukaiti RA; Shamim MS
J Pak Med Assoc; 2023 Aug; 73(8):1744-1746. PubMed ID: 37697779
[TBL] [Abstract][Full Text] [Related]
96. Adrenal Lymphoma: Case Reports and Mini-review.
Rezkallah EMN; Hanna RS; Elsaify WM
Int J Endocrinol Metab; 2022 Oct; 20(4):e128386. PubMed ID: 36714190
[TBL] [Abstract][Full Text] [Related]
97. Primary thyroid MALT lymphoma and treatment response demonstrated on FDG PET/CT.
Kesim S; Ozguven S
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Dec; ():. PubMed ID: 33390291
[No Abstract] [Full Text] [Related]
98. PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy.
Gao Y; Wu C; Chen X; Ma L; Zhang X; Chen J; Liao X; Liu M
Front Immunol; 2022; 13():1049043. PubMed ID: 36341331
[TBL] [Abstract][Full Text] [Related]
99. [18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases.
Evangelista L; Crimì F; Visentin A; Voltan G; Trentin L; Lacognata C; Cecchin D; Ceccato F
Curr Oncol; 2022 Oct; 29(10):7887-7899. PubMed ID: 36290900
[TBL] [Abstract][Full Text] [Related]
100. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
